戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 s increased by treatment with IL-4 or a beta-adrenergic receptor antagonist.
2 phages were prevented by propranolol, a beta-adrenergic receptor antagonist.
3 further inhibited by yohimbine, an alpha(2A)-adrenergic receptor antagonist.
4 ion of PI 3-kinase in the presence of a beta adrenergic receptor antagonist.
5 response was blocked by prazosin, an alpha 1-adrenergic receptor antagonist.
6 imes increased by treatment with IL-4 or a B-adrenergic receptor antagonist.
7 observed in control EAE mice treated with B1 adrenergic receptor antagonist.
8 nonmotor symptoms of PD that were rescued by adrenergic receptor antagonists.
9 ents with current or previous use of alpha-1 adrenergic receptor antagonists.
10 alterations of affinity values for selective adrenergic receptor antagonists.
11                       Pretreatment with beta-adrenergic receptor antagonists abolished differences in
12 c hyperplasia is commonly treated with alpha-adrenergic-receptor antagonists (alpha-blockers) or 5alp
13                                      Alpha-1 adrenergic receptor antagonists (alpha1-ARAs) are freque
14 ritical poisoning from benzodiazepines, beta-adrenergic receptor antagonists (also known as beta-bloc
15              Further, both propranolol (beta-adrenergic receptor antagonist) and prazosin (alpha1-adr
16 rtan (10 mg/kg b.wt) nor prazosin, an alpha1 adrenergic receptor antagonist, at doses of 5 microg/5 m
17                                Using a B(2) -adrenergic receptor antagonist (B(2) -AR), we find that
18                         For many years, beta-adrenergic receptor antagonists (beta-blockers or betaAR
19                                         beta-Adrenergic receptor antagonists (beta-blockers) are the
20 patients have shown that treatment with beta-adrenergic receptor antagonists (betaB) improves cardiac
21                     Cotreatment with a beta2-adrenergic receptor antagonist, butoxamine, suggests tha
22              The data also suggest that beta-adrenergic receptor antagonists can attenuate LPS-induce
23 anolol or nadolol or the alpha1- + beta1,2,3-adrenergic receptor antagonist carvedilol before or afte
24 riment examined whether prazosin, an alpha 1-adrenergic receptor antagonist, could attenuate NMDA-ind
25 ression, but pre-exposure to timolol, a beta-adrenergic receptor antagonist, delayed this effect.
26 agonist, or propranolol, a nonselective beta-adrenergic receptor antagonist, delivered by osmotic pum
27  prevented with either LTCC blockers or beta-adrenergic receptor antagonists, demonstrating a proxima
28 es on transendothelial resistance, whereas a-adrenergic receptor antagonists did not.
29               Furthermore, DA D1/D5 and beta-adrenergic receptor antagonists disrupted behavior, but
30                     Pretreatment with a beta-adrenergic receptor antagonist, esmalol, had no effect o
31          The affinity of selective alpha(1b)-adrenergic receptor antagonists for the switch mutant (D
32                                         Beta adrenergic receptor antagonists greatly reduce reactive
33                          More recently, beta-adrenergic receptor antagonists have been found to provi
34 ceptor antagonist phentolamine nor the beta2-adrenergic receptor antagonist ICI 118, 551 antagonized
35 s repeated after administration of the beta2-adrenergic receptor antagonist ICI 118,551 (0.2 mg/kg).
36 al peritonitis with dopexamine and the beta2-adrenergic receptor antagonist ICI 118,551 (n = 4), ceca
37 ked by administration of the selective beta2-adrenergic receptor antagonist ICI-118,551.
38 as prevented by prior injection of the beta2-adrenergic receptor antagonist ICI-118,551.
39 is before and during infusion of the alpha 2-adrenergic receptor antagonist idazoxan (1.0 microgram.k
40 d the proepileptogenic actions of the alpha2 adrenergic receptor antagonist idazoxan.
41 responses can be inhibited by alpha and beta-adrenergic receptor antagonists implying a bacterial rec
42   Most clinical studies have shown that beta-adrenergic receptor antagonists improve long-term surviv
43 ls testing rho-kinase inhibitors and alpha2c-adrenergic receptors antagonists in vasospastic conditio
44                   Neither norepinephrine nor adrenergic receptor antagonist infusion into the auditor
45                                 Only beta(1)-adrenergic receptor antagonists inhibited encystation, a
46 cocktail of alpha(1)-, beta(1)-, and beta(2)-adrenergic receptor antagonists into the mPFC prior to e
47                         Yohimbine, an alpha2 adrenergic receptor antagonist, is a well-validated phar
48  action for several compounds, including the adrenergic receptor antagonist JP1302, which we show dis
49                             Orthosteric beta-adrenergic receptor antagonists, known as beta-blockers,
50                 Systemic application of beta-adrenergic receptor antagonists may have detrimental eff
51                Here, we asked whether a beta-adrenergic receptor antagonist might interfere with the
52 hen compared with users of tamsulosin, an a1 adrenergic receptor antagonist of a different class that
53           Intraamygdala injections of a beta-adrenergic receptor antagonist or agonist, each timed to
54 ecursor, or with S(-) pindolol, a 5HT1A/beta adrenergic receptor antagonist or with LY206130, a more
55 h saline, phentolamine, a nonselective alpha-adrenergic receptor antagonist, or propranolol, a nonsel
56  effect was completely reversed by the alpha-adrenergic receptor antagonist phentolamine (i.p. and i.
57  4 h or by intravenous infusion of the alpha-adrenergic receptor antagonist phentolamine for only 30
58 the SPGN terminal, because neither the alpha-adrenergic receptor antagonist phentolamine nor the beta
59             Treatment of mice with the alpha-adrenergic receptor antagonist phentolamine prevented no
60                         Treatment with alpha-adrenergic receptor antagonists potentiated dopamine inh
61                                   The alpha1-adrenergic receptor antagonist prazosin (0.1 microM) blo
62 l fear conditioning, injections of the alpha-adrenergic receptor antagonist prazosin (1.0 or 3.0 mg/k
63 urrent to 5.9 nM, and addition of the alpha1-adrenergic receptor antagonist prazosin did not cause an
64 tions in MA but not in MV while the alpha(1)-adrenergic receptor antagonist, prazosin (0.1 microm), b
65               Pretreatment with the alpha(1)-adrenergic receptor antagonist, prazosin, and the alpha(
66                        The specific alpha(1)-adrenergic receptor antagonist, prazosin, inhibited the
67 Thy-1 mRNA levels were prevented by the beta-adrenergic receptor antagonist propranolol (10 microM).
68  30 mug) or vehicle (Experiment 1), the beta-adrenergic receptor antagonist propranolol (2 mug) or ve
69 ocked the effects of NA on Ito, but the beta-adrenergic receptor antagonist propranolol (20 microM) d
70            We probed the effects of the beta-adrenergic receptor antagonist propranolol (40 mg) using
71               We probed the effects of the B-adrenergic receptor antagonist propranolol (40 mg) using
72      We find that administration of the beta-adrenergic receptor antagonist propranolol before memory
73 lthy participants were administered the beta-adrenergic receptor antagonist propranolol or a placebo
74 t, treatment before hemorrhage with the beta-adrenergic receptor antagonist propranolol was associate
75                                     The beta-adrenergic receptor antagonist propranolol, administered
76  D2 antagonist spiperone but not by the beta-adrenergic receptor antagonist propranolol.
77 ubjected to the nonselective (beta1 + beta2) adrenergic receptor antagonists propranolol or nadolol o
78 bsence of a alpha2-agonist (clonidine), beta-adrenergic receptor antagonist (propranolol), and beta(1
79        Acute administration of a cocktail of adrenergic receptor antagonists (propranolol, prazosin,
80                            Although the beta-adrenergic receptor antagonist (-)-propranolol binds wit
81 ctivity was completely blocked by the alpha2-adrenergic receptor antagonist rauwolscine and by Clostr
82                                   B1- and B2-adrenergic receptor antagonists reduced the effects of t
83 ic receptor antagonist) and prazosin (alpha1-adrenergic receptor antagonist) reduced female but not m
84                    BACKGROUNDRecently the a1 adrenergic receptor antagonist terazosin was shown to ac
85           Propranolol is a nonselective beta-adrenergic receptor antagonist that is efficacious in re
86              Propranolol is a nonselective B-adrenergic receptor antagonist that is efficacious in re
87 ystment was inhibited by addition of beta(1)-adrenergic receptor antagonist to cells that were stimul
88 ies is also enhanced by administering a beta-adrenergic receptor antagonist to mice housed at 22 degr
89  nmol/L) or beta2- (ICI 118,551, 100 nmol/L) adrenergic receptor antagonist was also examined.
90 xed beta(1)/beta(2)- (timolol, metipranolol) adrenergic receptor antagonists were all shown to attenu
91 an melanocyte cell cultures with the alpha-2 adrenergic receptor antagonist yohimbine results in a ma
92 1 (CRF1) antagonist (antalarmin), and alpha2-adrenergic receptor antagonist (yohimbine; used as a pha
93 overflow for MA was enhanced by the alpha(2)-adrenergic receptor antagonist, yohimbine (1.0 microm),